Project Grant H79TI088525
- The National Institute on Drug Abuse awarded The Medical University of South Carolina $906,000 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and implement a training curriculum for Emergency Psychiatric Assessment, Treatment, and Healing (EMPATH) unit personnel focused on acute management of opioid use disorder with emphasis on medication for opioid use disorder initiation using buprenorphine. Phase 1 (R-61) of the project will focus on curriculum...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the University of Connecticut Health Center $300,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to develop a comprehensive substance use disorder education and clinical readiness program for health professional students. The University of Connecticut Comprehensive SUD Education and Clinical...
- The National Institute on Drug Abuse awarded Ohio University $1.965 million on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test the Buprenorphine Prescribing Support Program for rural primary care settings. The award funds a hybrid type 3 cluster randomized implementation effectiveness trial assessing whether a clinical training program paired with peer mentorship can expand buprenorphine prescribing and improve clinical outcomes in people with...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded The Martinsburg Initiative, Inc., $1,239,089 on September 30, 2025, under the Center for Substance Abuse Prevention Projects of Regional and National Significance program (CFDA 93.492). The Martinsburg Initiative will implement evidence-based programs and practices to prevent youth substance use among ages 9–20 in Berkeley County, West Virginia, targeting reduction of alcohol, marijuana,...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded the University of California, San Diego three hundred thousand dollars on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to develop and deliver comprehensive graduate education on substance use disorders. The award funds the UC San Diego Comprehensive Graduate Education for Substance Use Disorders...
- The Department of Health and Human Services Centers for Disease Control and Prevention, operating through the National Institute for Occupational Safety and Health, awarded Marshall University Research Corporation $149,956 on September 1, 2026, under the Occupational Safety and Health Program (CFDA 93.262) to support graduate training in environmental health and safety for Appalachian workforce transformation. The award funds development and delivery of graduate training curriculum and related...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment awarded the American Society of Addiction Medicine Inc. $2,999,542 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to implement the Providers Clinical Support System – Substance Use Disorder Treatment (PCSS-SUD Treatment). PCSS-SUD Treatment is a national training and technical assistance program...
- The Department of Health and Human Services Health Resources and Services Administration Bureau of Health Professionals awarded West Virginia University $498,605 under the Primary Care Training and Enhancement program (CFDA 93.884) on July 1, 2026, to establish residency training in street medicine for people experiencing homelessness in rural Appalachia. The project, titled "Inspire to Empower," expands street medicine education by establishing a required four-week rotation for PGY2...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Mississippi State University $375,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to expand access to evidence-based substance use disorder and dual diagnosis treatment for college-aged youth across Mississippi. The project will provide pro-bono substance use disorder or dual diagnosis...
- The National Institute on Drug Abuse awarded East Tennessee State University $129,640 on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to operate the East Tennessee State University Mentored Substance Use Research (EMSUR) summer program through January 31, 2031. EMSUR will train ten undergraduate students annually over five years through faculty-mentored substance use research, engagement with the digital Substance Use Research Education and Training (SARET)...
The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Marshall University Research Corporation $299,519 under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) on September 30, 2026. The award funds training of graduate-level health professional students to deliver substance use disorder services in rural and medically underserved areas of West Virginia. Marshall University's Physician Assistant Program will conduct Prescription Drug Monitoring Program-buprenorphine/opioid use disorder medications (PCSS-MOUD) training for students across four academic programs: the Physician Assistant Program, School of Pharmacy, Athletic Training Program, and Clinical Psychology Doctorate Program. The initiative expects to train 70 to 80 students annually, totaling 210 to 240 students over the three-year period. Physician Assistant students will receive additional education in clinical assessment, clinical medicine, pharmacology, and psychiatry; complete clinical rotations with exposure to patients with substance use disorders; and receive Narcan training. Faculty will administer the mandatory eight-hour PCSS MOUD curriculum across all participating programs. The award runs through September 29, 2029, with place of performance in Huntington, West Virginia. Marshall University Research Corporation is a nonprofit research organization affiliated with Marshall University.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $299.5k | 8/18/26 |